blog navigation

blog posts

  • New molecule heralds hope for muscular dystrophy treatment

    Illinois chemists -- from left, undergraduate Kali A. Miller, graduate students Amin Haghighat Jahromi and Lien Nguyen, and professor Steven C. Zimmerman – developed a small-molecule compound that could lead to therapeutic treatment for myotonic dystrophy, an as-yet untreatable disease.

    Photo by Ben Woloszyn


blog posts

  • Editor's note: To reach Steven C. Zimmerman, call 217-333-6655; email

    A proof version of the paper, “A Novel CUGexp·MBNL1 Inhibitor With Therapeutic Potential for Myotonic Dystrophy Type 1,” is available online.